The TPPP3 expression was significantly decreased in HNSC, bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIPC), lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC). Here, TPPP3 is linked to lung adenocarcinoma.